In the brain, prior sublethal ischemia (preconditioning, PC) produces tolerance of neurons to subsequent lethal ischemia. This study aims at elucidating whether and how nitric oxide (NO) produced during PC is involved in the PC-induced ischemic tolerance of neurons in neuron/ astrocyte co-cultures. The rise in the extracellular concentration of glutamate during ischemia caused by the reversed uptake of glutamate (Glu) by the astrocytic Glu transporter GLT-1 was markedly suppressed by the prior PC treatment, but the suppression was reversed by treatment with an inhibitor of nitric oxide synthase (NOS) during PC. Immunocytochemical and Western blot analyses demonstrated that the expression of GLT-1 was down-regulated after the PC insult, and this down-regulation was also antagonized by treatment with NOS inhibitors during PC. Here we show that nNOS-derived NO produced during PC was crucial for the down-regulation of astrocytic GLT-1, and this down-regulation coincided with an increased survival rate of neurons.
INTRODUCTION
Preconditioning (PC) to ischemic tolerance is a phenomenon in which a brief subtoxic insult induces robust protection against the deleterious effects of a subsequent, prolonged, lethal ischemia (1) . In the brain, Kitagawa et al. (2) first reported that gerbils subjected to sublethal transient global ischemia exhibited reduced hippocampal neuronal death after a severe ischemic insult 24-28 h later. We have recently demonstrated in mixed neuron/astrocyte cultures that the ischemia-induced rise in the extracellular concentration of L-glutamate (Glu) is significantly suppressed by prior PC treatment, and this suppression during ischemia primarily contributes to the PC-induced ischemic tolerance of neurons (3) .
Previous studies including by us have demonstrated that the astrocytic Glu transporter GLT-1 is primarily responsible for the clearance of extracellular Glu (4-7). These findings have led to the notion that a normal functioning astrocytic Glu transporter is crucial to the survival of neurons in the brain. Under conditions of brain ischemia, however, the role of astrocytic Glu transporters is reversed; that is, Glu is released from astrocytes to the extracellular space (8, 9) , resulting in a massive excitotoxic death of neurons.
We have previously revealed that the production of nitric oxide (NO) is increased during PC, and this enhanced NO production is crucial to the development of PC-induced neuronal ischemic toler-ance in cultured neurons (10) . In addition, we have recently revealed that in neuron/astrocyte co-cultures the expression of the astrocytic glutamate transporter GLT-1 is transiently down-regulated after PC treatment, and the ischemia-induced rise in the extracellular concentration of glutamate via a reversed uptake of glutamate by GLT-1 is significantly suppressed (3) . The question then arises as to whether NO produced during PC is involved in the PCinduced down-regulation of GLT-1, and in the resultant ischemic tolerance of neurons. In the present report, we provide experimental evidence that nNOS-derived NO produced during PC was crucial for the down-regulation of GLT-1, and for the increased neuronal resistance to subsequent severe ischemic insult.
EXPERIMENTAL PROCEDURE
The animal experiments conformed to the ''Principles of laboratory animal care'' (NIH publication No. 85-23, revised 1996), as well as the ''guide for the care and use of laboratory animals'', Hokkaido University School of Medicine.
Neuron/Astrocyte Co-Culture. Culture methods were described previously in detail (3, 4, 10, 11) . In brief, both neurons and astrocytes were prepared from 17-day-old embryonic rat cortices and grown in Dulbecco's modified Eagle's medium (DMEM, Gibco, Grand Island, NY) which was supplemented with 10% heatinactivated fetal bovine serum (FBS), 10% Ham's F12, and 0.24% penicillin/streptomycin (culture medium). Cells were plated at a uniform density of 3.0 Â 10 5 cells/cm 2 onto poly-L-lysine (100 lg/ ml)-coated plastic dishes and maintained in a 5% CO 2 incubator at 37°C. The cultures were fed a filtered (0.22 lm; Millipore, Bedford, TX) conditioned medium (CM) twice a week. To obtain the CM, cells from 16-to 18-day-old embryonic rat cortices were plated onto poly-L-lysine-coated 6-well dishes and cultured for more than 2 weeks. The cultures were then fed a cooled culture medium and incubated for an additional day. The culture medium was filtered and used as CM. After 13-15 days, the neurons in these cultures sit on the top of a confluent monolayer of astrocytes. The experiments were performed using these cultures.
Immunocytochemistry. Astrocytes and neurons were identified by immunostaining with antibodies against glial fibrillary acidic protein (GFAP; Sigma, St Louis, MO) and microtubule-associated protein 2 (MAP-2; Sigma), respectively. The astrocytic glutamate transporter GLT-1 was detected by immunostaining with anti-GLT-1 polyclonal antibodies (Chemicon, Temecula, CA). The NO synthases (NOSs) in cultured cells were detected by immunostaining with anti-neuronal NOS (nNOS) (Euro-Diagnostica, Sweden), anti-endothelial NOS (eNOS) (Transduction Lab., Lexington, KY), or anti-inducible NOS (iNOS) (Transduction Lab.). For the labeling of MAP-2, GFAP, GLT-1, nNOS, iNOS, and eNOS, the cortical cells were fixed with 4% paraformaldehyde for 5 min at 4°C, followed by 95% methanol in phosphate-buffered saline (PBS) for 10 min at )20°C. The cells were then incubated with a primary antibody over a 24-h period using a dilution of 1:1000 for MAP-2, 1:400 for GFAP, 1:2500 for GLT-1, 1:1000 for nNOS, 1:1000 for eNOS, and 1:5000 for iNOS. After being washed with PBS, the cells were incubated with a secondary antibody containing 1.0% goat serum for 30 min. For labeling, a 1:500 dilution of biotinylated goat antibody against mouse or guinea pig IgG (Vector Laboratories, Burlingame, CA) was used. Bound antibodies were detected by the avidin-biotinperoxidase complex (ABC) method, using a commercial ABC kit (Vector Laboratories). Observation of the peroxidase activity was made possible by incubation with 0.1% 3,3¢-diaminobenzidine tetrahydrochloride (DAB) in a 50 mM Tris-HCl buffer (pH 7.4) supplemented with 0.02% H 2 O 2 . The cells were dehydrated in 70-100% ethanol, cleared in xylene, and mounted on glass coverslips in Permount (Fisher Scientific, Fair Lawn, NJ) for light microscopic observation.
Western Blot Analysis. Cell lysates were diluted 3:1 in sample buffer (187.5 mM Tris-HCl containing 6% SDS, and 15% glycerol, 15% 2-mercaptoethanol) and denatured at 100°C for 3 min. Proteins (40 lg for co-cultures, 20 lg for astrocyte-enriched cultures per lane) were electrophoresed on a 10% SDS-polyacrylamide gel and transferred onto a polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA). Nonspecific binding sites were blocked with 5% non-fat milk for 60 min, and then the membrane was incubated overnight at 4°C with one of the following antibodies: polyclonal antibody to GLT-1 (1:10,000), GLAST (1:8000) (Chemicon, Temecula, CA), and monoclonal antibody to actin Oxygen-Glucose Deprivation. Cortical cultures were subjected to oxygen-glucose deprivation (OGD) injury using a protocol described previously (11, 12) . In brief, cultures were placed in an anaerobic chamber and washed two times with a balanced salt solution (BSS: 116 mM NaCl, 0.8 mM MgSO 4 , 5.4 mM KCl, 1.0 mM NaH 2 PO 4 , 26.2 mM NaHCO 3 , 1.8 mM CaCl 2 , 0.01 mM glycine, and 10 mg/l phenol red) lacking glucose. Near anoxic conditions were achieved using an Anaero-Pack System (Mitsubishi Gas Chemical, Tokyo, Japan). After pre-gassing with 95% N 2 -5% CO 2 for at least 5 min to remove residual oxygen, glucose-free BSS was added to the cells, which were then placed in a purposebuilt sealed chamber containing the deoxygenation reagent (Kenki for Cells, Mitsubishi Gas Chemical, Tokyo, Japan). The catalytic reaction of the reagent resulted in the consumption of O 2 and production of CO 2 . This Anaero-Pack System provided near anaerobic conditions with an O 2 concentration of <1% and a CO 2 concentration of about 5% within 1 h of incubation at 37°C. Cells were exposed to these conditions for a designated period to produce either mild (sublethal) or lethal OGD. To terminate OGD, cultures were carefully washed with glucose (20 mM) containing BSS, and then incubated again in culture medium at 37°C in 95% air-5% CO 2 (reperfusion). Cultures with sham treatment not deprived of oxygen and glucose were placed in BSS containing 20 mM glucose. In some experiments, BSS was prepared with no added calcium salts and the addition of 2 mM EGTA and 1.8 mM MgCl 2 . For the measurement of the NADH fluorescence, cultures were washed two times with BSS without glucose and phenol red. After washing, glucose-free BSS (containing 50 U/ml GDH, 2 mM NAD + , 4 U/ml GPT, and 2 mM L-alanine) without phenol red was added to the cultures. The cultures were then placed in a purpose-built sealed chamber made of acrylic resin and glass for transmitting UV light containing the deoxygenation reagent, and examined under a fluorescent microscope (Olympus, IX70, Tokyo, Japan).
Measurement of the Concentration of Extracellular Glutamate. The concentration of extracellular glutamate (Glu) was measured using an enzymatic assay (13, 14) . In the presence of Glu and b-nicotinamide adenine dinucleotide (NAD + ), L-glutamic dehydrogenase (GDH) produces a-ketoglutarate and NADH, a product that fluoresces when excited at 360 nm. In the presence of a-ketoglutarate and L-alanine, glutamate pyruvate transaminase (GPT) produces L-glutamate. Therefore, GDH (50 U/ml), NAD + (2 mM), GPT (4 U/ml), and L-alanine (2 mM) were added to the external solution, and the fluorescence was excited at 360 nm and detected at >510 nm with a fluorescent microscope. Images excited at 360 nm were acquired with integration times of 5 s at intervals of 20 s. The extracellular Glu was detected as an increase in NADH fluorescence. This method does not necessarily reflect the quantitative extracellular Glu level, but can detect subtle changes in the concentration of Glu. Fluorescent images were acquired with a cooled CCD camera (C4880-80; Hamamatsu Photonics, Hamamatsu, Japan). An analysis of the acquired images was conducted with an image processing and measuring system (AQUACOSMOS; Hamamatsu Photonics).
Survival Rate of Neurons. Neuronal death was analyzed following observation of the nuclear morphology using the fluorescent DNA-binding dyes, Hoechst 33342 (H33342) and propidium iodide (PI). Cells were incubated with these dyes for 15 min at 37°C. Individual nuclei were observed using fluorescent microscopy (Olympus, IX70, Tokyo, Japan) and subsequently analyzed. PI was used to identify nonviable cells. More specifically, an average of 450-500 neurons from random fields were analyzed in each experiment. The survival rate of neurons-meaning the percentage of viable neurons remaining-was determined by placing images of nuclear staining on phase-contrast images, and calculating (viable neurons/total neurons before drug treatment)Â100, since some neurons came off the dishes at the time of inspection. At least four independent experiments (n ‡ 4) were conducted and analyzed.
Chemicals. N G -monomethyl-L-arginine (L-NMMA), Bisbenzimide (Hoechst 33342), and propidium iodide (PI) were obtained from Sigma. N 5 -(1-imino-3-butenyl)-L-ornithine (L-VNIO) was obtained from ALEXIS Japan (Tokyo, Japan). The other chemicals were from Wako Chem. (Tokyo, Japan).
Statistics. Data were presented as means with standard deviation. Multiple comparisons were conducted using an analysis of variance (ANOVA) with Sheffe's t-test. A P-value of less than 0.01 or 0.05 was considered statistically significant.
RESULTS
We have recently revealed that the exposure of neuron/astrocyte co-cultures to a sublethal ischemic insult (preconditioning) results in a significant suppression of the rise in the concentration of extracellular glutamate (Glu) during subsequent lethal ischemia, and this suppression is a primary cause of PC-induced neuronal ischemic tolerance (3). In addition, we also demonstrated the possibility that NO produced during PC is involved in the development of the PC-induced ischemic tolerance of neurons (10) . Therefore, we first investigated whether the PC-induced suppression of the rise in the concentration of extracellular Glu was antagonized by the inhibition of NO production during PC in neuron/ astrocyte co-cultures (Fig. 1) . Lethal ischemia (90 min OGD) resulted in a marked elevation of the concentration of extracellular Glu (Fig. 1B, E, F) . The elevation was significantly decreased by prior PC (60 min OGD) treatment 24 h before the onset of lethal OGD (Fig. 1C, E, F) . However, this PC-induced suppression of the rise in extracellular Glu was significantly reversed by the treatment of cultures with N G -monomethyl-L-arginine (L-NMMA; 1 mM), a non-specific inhibitor of NOS during PC (Fig. 1D , E, F). This result suggested that NO produced during PC was crucial to the PC-induced suppression of the rise in the concentration of extracellular Glu during lethal ischemia.
We have recently reported that a PC insult transiently decreases the level of the astrocytic Glu transporter GLT-1, and this decreased expression contributes to the suppression of the rise in extracellular Glu via a reversed uptake of Glu by GLT-1 during lethal ischemia (3). Therefore, we then investigated whether NO is involved in the PC-induced down-regulation of the expression of GLT-1 by conducting immunocytochemical as well as Western blot analyses (Fig. 2) . The expression of astrocytic GLT-1 was significantly decreased 24 h after the PC (Fig. 2A1, B1, D2 ), but this down-regulation was significantly reversed by treatment with L-NMMA (1 mM) during PC (Fig. 2A1, B1, D3 ). In contrast, the expression level of GLAST was not significantly changed ( Fig. 2A2-C2 ).
Our previous study has revealed that PC-induced neuronal ischemic tolerance was attenuated by treatment with a blocker of Ca 2+ -permeable NMDA receptors during PC (11), suggesting that Ca 2+ -dependent NOS was involved in the PC-induced tolerance. We thus investigated the expression of NOS isoforms in our neuron/astrocyte co-cultures. The neurons in our co-cultures expressed neuronal NOS (nNOS) (Fig. 3H1) , but the distinct expression of neither inducible NOS (iNOS) (Fig. 3H2 ) nor endothelial NOS (eNOS) (Fig. 3H3) was detected in the co-cultures. Therefore, we investigated whether the activation of Ca 2+ -dependent nNOS during PC was crucial to the development of PC-induced neuronal ischemic tolerance. Lethal (90 min) OGD resulted in a significant death of neurons inspected at 24 h after the end of the insult (Fig. 3A, D) . In contrast, exposure of preconditioned cultures to the lethal OGD 24 h later resulted in a significant increase in the survival rate of neurons (Fig. 3B, D) . However, this PC-induced protective effect on neurons was significantly antagonized by treatment with vinyl-L-NIO (L-VNIO; 100 lM), a potent specific inhibitor of nNOS (15) , during PC (Fig. 3C, D) . Furthermore, we investigated whether the production of NO via the activation of nNOS during PC was also critical to the PC-induced down-regulation of GLT-1 by conducting immunocytochemical as well as Western blot analyses. The expression of GLT-1 was decreased 24 h after the exposure to the prior PC, but the decrease was significantly reversed when the activity of nNOS was inhibited by treatment with and L-VNIO (100 lM) during PC (Fig. 3E1, F1 ). In contrast, the expression of GLAST did not change significantly (Fig. 3E2-G2 ). These results suggested that nNOS-derived NO produced during PC contributed to the PC-induced decrease in the expression of GLT-1 and to the development of the PC-induced ischemic tolerance of neurons in the neuron/astrocyte co-cultures. Figures A1 and A2 show the results of immunostaining of the cultures using anti-MAP-2 (A1) and anti-GFAP (A2) antibodies, indicating that the cultures were mixed. Photomicrographs B1, C1, and D1 show phase-contrast images of the mixed neuron/astrocyte cultures. Figures B2-B3 , C2-C3, and D2-D3 illustrate a pseudo-color representation of NADH fluorescence reflecting the extracellular concentration of Glu when the sham-treated cultures (B2, B3), the cultures preconditioned 24 h before (C2, C3), and the cultures preconditioned with L-NMMA (1 mM) (D2, D3), were exposed to OGD, respectively. The fluorescence intensity increases from dark blue to red through yellow. Figure E shows a time course of the change in the NADH fluorescence ratio during OGD in the sham-treated cultures (blue), in the preconditioned cultures (orange), and in the cultures preconditioned with L-NMMA treatment (red), respectively. The OGD begins at 0 min. Vertical bars indicate +SD. Neither neurons nor astrocytes were degenerated at all at 90 min after the start of OGD (lethal OGD). Figure F 
DISCUSSION
The present study demonstrated that nNOS-derived NO produced during sublethal PC was crucial for the PC-induced down-regulation of GLT-1 and the increased neuronal resistance to a subsequent severe ischemic insult.
Although numerous studies have reported increased tolerance to ischemia following preconditioning of the mammalian brain with OGD, cortical 05. An immunocytochemical analysis of the co-cultures using anti-GLT-1 antibody revealed that the PC insult down-regulated astrocytic GLT-1 24 h after the end of the PC (D2), but the PC-induced down-regulation was antagonized by the treatment with L-NMMA (1 mM) (D3). Figure D1 shows GLT-1 expression in the sham-treated cultures. GLT-1-positive astrocytes were identified just underneath the aggregate of neurons similar to our previous observations (4). GLT-1-positive neurons were not detected. The scale bar indicates 200 lm.
spreading depression (CSD), or middle cerebral artery occlusion (MCAO), the mechanism underlying this neuroprotection is unclear (16) (17) (18) (19) . Some studies have reported that neurons themselves acquire resistance against ischemia through preconditioning (18, 19) . We have recently reported that the expression of the astrocytic glutamate transporter GLT-1 is transiently decreased after prior PC and contributes to the PC-induced neuronal resistance to subsequent severe ischemic insult, suggesting that the PC-induced changes in glial function; that is, the down-regulation of astrocytic GLT-1 expression, seems critical to the PC-induced ischemic tolerance of neurons (3) .
NO is generated in various mammalian tissues, and acts as an intercellular messenger associated with various physiological and pathological events (20) . Recently, we have demonstrated that the activity of NOS varies with the differentiation of a neuronal cell line (NG108-15 cells), suggesting that NO functions as an important signaling molecule in differentiated NG108-15 cells (21) . We have also found that NO modulates the propagation of astrocytic Ca 2+ waves induced by the local photolysis of a caged Ca 2+ ionophore (22, 23) . In addition, Yun et al. (24) have recently demonstrated that the activation of p21 RAS induced by NO derived from nNOS is responsible for the PC-induced tolerance of neurons, suggesting that NO is a key mediator in the process leading to resistance against lethal ischemia. We have previously demonstrated that the enhanced production of NO is crucial to the development of PC-induced ischemic tolerance of neurons in neuron/astrocyte co-cultures (10) . However, the underlying mechanisms responsible for the NO-induced ischemic tolerance have not been fully elucidated. The present study suggested that the production of NO during PC was crucial for the PC-induced down-regulation of GLT-1. The decrease in the expression of GLT-1 seemed crucial for the increased neuronal resistance to a subsequent severe ischemic insult.
We have previously demonstrated that treatment of neuron/astrocyte co-cultures with a blocker of NMDA receptors during PC antagonized the PCinduced ischemic tolerance of neurons (11), suggesting that the activation of Ca 2+ permeable NMDA receptors during PC is involved in the development of the PC-induced neuronal ischemic tolerance. In addition, the present study has suggested that the Ca 2+ -dependent nNOS-derived NO produced during PC was critically involved in the PC-induced down-regulation of astrocytic GLT-1, and in the PCinduced ischemic tolerance of neurons. However, the question arises as to what mechanisms are responsible for the NO-induced down-regulation of the glutamate transporter GLT-1. Further studies will be needed to clarify these mechanisms. Fig. 3 . Activation of nNOS during PC is crucially involved in the development of PC-induced neuronal ischemic tolerance and in the down-regulation of astrocytic glutamate transporter GLT-1. Photomicrographs A, B and C are images 24 h after the end of OGD when the sham-treated cultures (A), the preconditioned cultures (B), and the preconditioned cultures treated with L-VNIO (100 lM) (C) were exposed to lethal ischemia (LI) for 90 min OGD, respectively. Photomicrographs A1, B1 and C1 show the cultures before the exposure to LI, whereas A2, B2 and C2 illustrate their state 24 h after the exposure, respectively. Cell nuclei were stained with bisbenzimide (Hoechst 33342) and propidium iodide (PI) (A3, B3 and C3). Red nuclei in A3, B3 and C3 indicate PI-positive dead neurons. Figure D 
